Sector: Professional, Scientific, and Technical Services Industry: Research and Development in Biotechnology
52 week range:
3.36 - 24.34
Organogenesis Holdings Inc. is a leading regenerative medicine company offering a portfolio of bioactive and acellular biomaterials products in advanced wound care and surgical biologics, including orthopedics and spine. Organogenesis's comprehensive portfolio is designed to treat a variety of patients with repair and regenerative needs.